A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet

被引:1
|
作者
Hall, Rosemary M. [1 ,2 ]
Marshall, Hannah J. [1 ,2 ]
Parry-Strong, Amber [2 ]
Corley, Brian [1 ,2 ]
Krebs, Jeremy D. [1 ,2 ]
机构
[1] Univ Otago Wellington, Dept Med, POB 7343, Wellington 6012, New Zealand
[2] Wellington Reg Hosp, Ctr Endocrine Diabet & Obes Res CEDOR Wellington, Level 5,Grace Neill Block,Riddiford St, Wellington, New Zealand
关键词
Diabetes mellitus; Type; 1; Dietary carbohydrates; Dietary proteins; FAT; CHILDREN; ADULTS; PUMP;
D O I
10.1016/j.jdiacomp.2024.108778
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Postprandial hyperglycemia can be problematic for people with type 1 diabetes (T1DM) following carbohydrate-restricted diets. Bolus insulin calculated for meal protein plus carbohydrate may help. This study evaluated the effect of additional bolus insulin using an insulin-to-protein ratio (IPR) on glycaemic control. Materials and methods: Participants with T1DM aged >= 18-years were randomly allocated (1:1) to either carbohydrate and protein-based, or carbohydrate-based insulin dosing alone for 12 weeks while following a carbohydrate-restricted diet (50-100 g/day). Measurement of HbA1c and continuous glucose monitoring occurred at baseline and 12 weeks, with assessment of participant experience at 12 weeks. Results: Thirty-four participants were randomised, 22 female, mean(SD): age 39.2 years (12.6) years; diabetes duration 20.6 years (12.9); HbA1c 7.3 % (0.8), 56.7 mmol/mol (9.2). Seven in each group used insulin pump therapy. HbA1c reduced at 12 weeks with no difference between treatments: mean (SD) control 7.2 % (1.0), 55.7 mmol/mol (10.6); intervention 6.9 % (0.7), 52.3 mmol/mol (7.2) (p = 0.65). Using additional protein-based insulin dosing compared with carbohydrate alone, there was no difference in glycaemic variability, time spent in euglycemic range (TIR), or below range. Participants using IPR reported more control of their diabetes, but varying levels of distress. Conclusions: Additional bolus insulin using an IPR did not improve glycaemic control or TIR in patients with well controlled T1DM following a carbohydrate-restricted diet. Importantly, the use of the IPR does not increase the risk of hypoglycemia and may be preferred.
引用
收藏
页数:7
相关论文
共 24 条
  • [1] The effect of additional mealtime insulin bolus using an insulin-to-protein ratio compared to usual carbohydrate counting on postprandial glucose in those with type 1 diabetes who usually follow a carbohydrate-restricted diet: A randomized cross-over trial
    Krebs, Jeremy D.
    Arahill, Jacob
    Cresswell, Pip
    Weatherall, Mark
    Parry-Strong, Amber
    DIABETES OBESITY & METABOLISM, 2018, 20 (10) : 2486 - 2489
  • [2] A flexible diet using an insulin to carbohydrate ratio for adolescents with type 1 diabetes - A pilot study
    Hayes, Rachel L.
    Garnett, Sarah P.
    Clarke, Samantha L.
    Harkin, Nuala M.
    Chan, Albert K. F.
    Ambler, Geoffrey R.
    CLINICAL NUTRITION, 2012, 31 (05) : 705 - 709
  • [3] OptimAAPP, a smartphone insulin dose calculator for carbohydrate, fat, and protein: A cross-over, randomised controlled trial in adolescents and adults with type 1 diabetes using multiple daily injection therapy
    Smith, Tenele A.
    Venkatesh, Nisha
    Roem, Kerryn
    Lu, Jean C.
    Netzer, Emma
    Medioli, Adrian
    Szwec, Stuart
    O'Neal, David N.
    King, Bruce R.
    Smart, Carmel E.
    DIABETIC MEDICINE, 2024,
  • [4] An additional bolus of rapid-acting insulin to normalise postprandial cardiovascular risk factors following a high-carbohydrate high-fat meal in patients with type 1 diabetes: A randomised controlled trial
    Campbell, Matthew D.
    Walker, Mark
    Ajjan, Ramzi A.
    Birch, Karen M.
    Gonzalez, Javier T.
    West, Daniel J.
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (04) : 336 - 344
  • [5] The relationship between meal carbohydrate quantity and the insulin to carbohydrate ratio required to maintain glycaemia is non-linear in young people with type 1 diabetes: A randomized crossover trial
    Cordon, Natalie M.
    Smart, Carmel E. M.
    Smith, Grant J.
    Davis, Elizabeth A.
    Jones, Timothy W.
    Seckold, Rowen
    Burckhardt, Marie-Anne
    King, Bruce R.
    DIABETIC MEDICINE, 2022, 39 (02)
  • [6] Prospective evaluation of insulin-to-carbohydrate ratio in children and adolescents with type 1 diabetes using multiple daily injection therapy
    Hegab, Ahmed M.
    PEDIATRIC DIABETES, 2019, 20 (08) : 1087 - 1093
  • [7] Efficacy of Carbohydrate Supplementation Compared With Bolus Insulin Dose Reduction Around Exercise in Adults With Type 1 Diabetes: A Retrospective, Controlled Analysis
    Eckstein, Max L.
    McCarthy, Olivia
    Tripolt, Norbert J.
    Mueller, Alexander
    Birnbaumer, Philipp
    Pferschy, Peter N.
    Hofmann, Peter
    Bracken, Richard M.
    Sourij, Harald
    Moser, Othmar
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (08) : 697 - 700
  • [8] Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1)
    Hirsch, I. B.
    Franek, E.
    Mersebach, H.
    Bardtrum, L.
    Hermansen, K.
    DIABETIC MEDICINE, 2017, 34 (02) : 167 - 173
  • [9] Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials
    Rose, Ludger
    Kadowaki, Takashi
    Pieber, Thomas R.
    Buchholtz, Kristine
    Ekelund, Magnus
    Gorst-Rasmussen, Anders
    Philis-Tsimikas, Athena
    DIABETES THERAPY, 2019, 10 (03) : 1029 - 1041
  • [10] Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial
    Secher, Anna Lilja
    Pedersen-Bjergaard, Ulrik
    Svendsen, Ole L.
    Gade-Rasmussen, Birthe
    Almdal, Thomas
    Raimond, Linda
    Vistisen, Dorte
    Norgaard, Kirsten
    DIABETOLOGIA, 2021, 64 (12) : 2713 - 2724